-
Roche Holding AG Chairman Franz Humer said he won’t stand for re-election next year, ending more than a decade of leadership of the world’s biggest maker of cancer medicines.
-
Roche Holding AG Chairman Franz Humer may have put a lid for now on a year’s worth of speculation by telling a Swiss newspaper that a Roche deal to buy U.S. genetics company Illumina Inc. is off the table. Illumina shares fell the most in 15 months.
-
Roche Holding AG, the world’s largest maker of cancer drugs, looks forward to the “swift completion” of its takeover offer for Illumina Inc., a spokesman said.
-
Illumina Inc. gained the most in almost a year after Swiss newspaper L’Agefi said Roche Holding AG may have agreed to buy the U.S. maker of DNA sequencing equipment at a price 48 percent higher than its original unsuccessful bid.
-
Illumina Inc., a U.S. maker of DNA sequencing equipment, fell the most in 15 months after Roche Holding AG indicated it may no longer be interested in buying the company.
-
Roche Holding AG’s $6.7 billion public bid to buy Illumina Inc. stopped the gene-sequencing company’s board from discussing what price would be acceptable and may have scuttled a possible deal, according to Chief Executive Officer Jay Flatley.
-
Roche Holding AG favors acquisitions of as much as $7 billion over spending cash on share buybacks, Chief Financial Officer Alan Hippe told Bloomberg Industries analysts at a meeting.
-
Spain’s pharmaceutical lobby is negotiating with authorities a plan to sell state-guaranteed securities backed by 5.4 billion euros ($7.1 billion) of unpaid bills, Farmaindustria Director General Humberto Arnes said.
-
Roche Holding AG may get the first signs at a cardiology conference this month that the Swiss drugmaker can garner $6.8 billion in sales with a pill to combat heart disease by raising so-called good cholesterol.
-
Roche Holding AG Chief Financial Officer Erich Hunziker will step down and be replaced by ThyssenKrupp AG’s Alan Hippe , according to a person with knowledge of the situation.
Rate this Page